Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gilenya in Acute Ischemic Stroke with Alteplase and Mechanical Thrombectomy
NCT04675762Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2021
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of fingolimod in ischemic stroke, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jan 2021; status: recruiting.
02
Drugs
fingolimod
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04675762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04675762.